MSLN and pancreatic neoplasm: When simultaneous immunohistochemical staining for IMP3 and mesothelin was performed on pancreatic cancer, chronic pancreatitis, and normal pancreatic tissues, the sensitivity was 85% and specificity was 90% [35].